While it may seem strange that politics could impact the price of popular weight loss drugs, it is a definite possibility.

Weight loss drugs are popular—but often expensive. Luckily, there are a few ways to lower the costs, which we explore in this article.

Operator Ladies and gentlemen, thank you for standing by and welcome to the Lilly Q4 2024 earnings call. [Operator ...

Popular brands include Ozempic, Wegovy, and Mounjaro ... A handful of weight loss drug manufacturers issue copay cards that offer savings on expensive brand-name medications.

Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 ... that’s based on a drug’s list price (rather than a flat co-pay), Cubanski said. Those not enrolled in Medicare will not benefit ...

Hims & Hers offers a copycat of the blockbuster weight-loss drug at a fraction of the cost. But it might be a short-lived ...

The move could mean savings for consumers. Weight loss drugs Ozempic and Wegovy have been added to the list of medications Medicare will be able to negotiate directly with drug manufacturers ...

Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.